Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 37
Selected: 0
NCT IDTitle
NCT02052739Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus
NCT0535882128-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease
NCT04025502Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects
NCT02433314An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus
NCT03665038A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)
NCT04928703Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers
NCT05049343Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants
NCT02942004A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)
NCT02285504Evaluate SAGE-547 in Female Participants With Severe Postpartum Depression
NCT05173012Study to Evaluate SAGE-324 in Participants With Essential Tremor
NCT06580444Brexanolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study
NCT05543746Dynamic Neural Mechanisms of Brexanolone-induced Antidepressant Effects in Postpartum Depression
NCT01246765National Pregnancy Registry for Psychiatric Medications
NCT05655520A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease
NCT03771586A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects
NCT02942017A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)
NCT04476017A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)
NCT04602624A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
NCT02277106Evaluate SAGE-547 in Participants With Essential Tremor
NCT05314153Effects Zulresso on Postpartum Psychosis
NCT04537806A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19)
NCT04305275A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor
NCT05059600A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting
NCT02477618A Study With SAGE-547 for Super-Refractory Status Epilepticus
NCT03787758A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B
NCT05645432An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus
NCT05223829Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder
NCT03770780A Study to Assess the Electrophysiology, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response Using Magnetic Resonance Imaging of SAGE-718 Using a Ketamine Challenge in Healthy Subjects
NCT04273191A Study to Evaluate Multimodal Neuroimaging Parameters in Women With Postpartum Depression Who Are Receiving ZULRESSO™ (Brexanolone)
NCT05619692A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
NCT03924492Expanded Access Protocol of ZULRESSO™ (Brexanolone) Injection for Adult Patients With Postpartum Depression
NCT05107128A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)
NCT03844906A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects
NCT05318937A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment
NCT05366751A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor
NCT02614547A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression
NCT05254405An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder